Stocktoria
Viking Therapeutics, Inc. VKTX
Viking Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 6,026,131 | $319.4M | 5.25% |
| TWO SIGMA INVESTMENTS, LP | 4,432,142 | $144.2M | 3.86% |
| CITADEL ADVISORS LLC | 2,615,121 | $85.1M | 2.28% |
| D. E. Shaw & Co., Inc. | 1,676,713 | $54.6M | 1.46% |
| MILLENNIUM MANAGEMENT LLC | 376,225 | $12.2M | 0.33% |
| Bridgewater Associates, LP | 71,229 | $2.3M | 0.06% |
| Point72 Asset Management, L.P. | 19,000 | $618,260 | 0.02% |
| AQR CAPITAL MANAGEMENT LLC | 12,172 | $390,000 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.